METHOTREXATE SODIUM PRESERVATIVE FREE Drug Patent Profile
✉ Email this page to a colleague
When do Methotrexate Sodium Preservative Free patents expire, and when can generic versions of Methotrexate Sodium Preservative Free launch?
Methotrexate Sodium Preservative Free is a drug marketed by Accord Hlthcare, Eugia Pharma Speclts, Hikma, Hospira, Pharmachemie Bv, Rising, Sagent Pharms Inc, and Sandoz. and is included in thirteen NDAs.
The generic ingredient in METHOTREXATE SODIUM PRESERVATIVE FREE is methotrexate sodium. There are twenty drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the methotrexate sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Methotrexate Sodium Preservative Free
A generic version of METHOTREXATE SODIUM PRESERVATIVE FREE was approved as methotrexate sodium by HIKMA on September 16th, 1986.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METHOTREXATE SODIUM PRESERVATIVE FREE?
- What are the global sales for METHOTREXATE SODIUM PRESERVATIVE FREE?
- What is Average Wholesale Price for METHOTREXATE SODIUM PRESERVATIVE FREE?
Summary for METHOTREXATE SODIUM PRESERVATIVE FREE
US Patents: | 0 |
Applicants: | 8 |
NDAs: | 13 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 40 |
Clinical Trials: | 1 |
Patent Applications: | 4,433 |
DailyMed Link: | METHOTREXATE SODIUM PRESERVATIVE FREE at DailyMed |
Recent Clinical Trials for METHOTREXATE SODIUM PRESERVATIVE FREE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Cooperative Study Group A for Hematology | Phase 3 |
See all METHOTREXATE SODIUM PRESERVATIVE FREE clinical trials
Pharmacology for METHOTREXATE SODIUM PRESERVATIVE FREE
Drug Class | Folate Analog Metabolic Inhibitor |
Mechanism of Action | Folic Acid Metabolism Inhibitors |